FDA 483 - Jazz Imaging - October 24, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Jazz Imaging in San Jose, CA, from October 12-24, 2022, revealed significant deficiencies in its quality system as a medical device manufacturer. The firm failed to adequately document management reviews, training, supplier evaluations, process validations, equipment calibrations, quality audits, complaint investigations, and corrective and preventive actions. Additionally, the company did not perform required IQ/OQ/PQ for manufacturing equipment.
ID · d0c9a8ad-1446-4e7e-8af5-c93e013696cb